Depressive Symptoms and CD4 Lymphocyte Decline Among HIV-Infected Men

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 21, 1993, Pages 2568-2573

  Burack, Jeffrey H ^a   Barrett, Donald C ^b   Stall, Ron D ^b   Chesney, Margaret A ^b   Ekstrand, Maria L ^b   Coates, Thomas J ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIGEN P24; ANTIVIRUS AGENT; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ZIDOVUDINE;

ADULT; ARTICLE; BISEXUALITY; COHORT ANALYSIS; DEPRESSION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; SYMPTOMATOLOGY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DEPRESSION; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0027443759     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510210054027     Document Type: Article

References (30)

1. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990;301:1183-1188.
2. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ. 1988; 296:745-750.
3. Fahey JL, Taylor JM, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990;322:166-172.
4. Goedert JJ, Biggar RJ, Melbye M, et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA. 1987;257:331-334.
5. Kemeny ME. Psychoneuroimmunology of HIV infection. In: Zegans L, Coates TJ, eds. Neuropsychiatric Complications of HIV Disease. Philadelphia, Pa: WB Saunders Co. In press.
6. Solomon GF. Psychoneuroimmunology and human immunodeficiency virus infection. Psychiatr Med. 1989;7:47-57.
7. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993;113:472-486.
8. Glaser R, Kiecolt-Glaser J. Stress-associated depression of cellular immunity: implications for acquired immune deficiency syndrome (AIDS). Brain Behav Immun. 1987;1:107-112.
9. Persky VW, Kempthorne-Rawson J, Shekelle RB. Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med. 1987;49: 435-444.
10. Hays RB, Turner H, Coates TJ. Social support, AIDS-related symptoms and depression among gay men. J Consult Clin Psychol. 1992;60:463-469.
11. Rabkin JG, Remien R, Katoff L, Williams JB. Resilience in adversity among long-term survivors of AIDS. Hosp Community Psychiatry. 1993;44:162-167.
12. Winkelstein W, Lyman DM, Padian N, et al. Sexual practices and risk of infection by the human immunodeficiency virus: The San Francisco Men's Health Study. JAMA. 1987;257:321-325.
13. Lang W, Anderson RE, Perkins H, et al. Clinical, immunologic and serologic findings for men at risk for acquired immunodeficiency syndrome: The San Francisco Men's Health Study. JAMA. 1987;257:326-330.
14. Piazza T. Sampling Methods and Wave 1 Field Results of the San Francisco Men's Health Study: A Report to the National Institute of Allergy and Infectious Diseases. Berkeley, Calif: Survey Research Center, University of California, Berkeley; 1986. Technical Report 3. 1989.
15. Royce RA, Luckmann RS, Fusaro RE, Winkelstein W. The natural history of HIV-1 infection: staging classifications of disease. AIDS. 1991;5:355-364.
16. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1:385-401.
17. Valentine FT, Jacobson MA. Immunological and virological surrogate markers in the evaluation of therapies for HIV infection. AIDS. 1990;4(suppl 1): S201-S207.
18. Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR. Immune activation markers and AIDS prognosis. AIDS. 1991;5:505-511.
19. Hoover DR, Graham NMH, Chen B, et al. Effect of CD4 + cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr. 1992; 5:794-802.
20. Ekstrand M, Coates T. Maintenance of safer sexual behaviors and predictors of risky sex: The San Francisco Men's Health Study. Am J Public Health. 1990;80:973-977.
21. DeGruttola V, Lange N, Dafni U. Modeling the progression of HIV infection. J Am Stat Assoc. 1991; 86:569-577.
22. Centers for Disease Control and Prevention. Revision of the case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1987;36(suppl 2S):1-15.
23. Ascher MS, Sheppard HW, Winkelstein W, Vittinghoff E. Does drug use cause AIDS? Nature. 1993;362:103-104.
24. Hopkins A. Survival analysis with covariates. In: Dixon WJ, Brown MN, Engelman L, Jennrich RI, eds. BMDP Statistical Software Manual. Los Angeles: University of California Press; 1990:769-806.
25. Bornstein RA, Nasrallah HA, Para MF, Fass RJ, Whitacre CC, Rice RR. Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol. 1991;48:704-707.
26. Katz MH, Bindman AB, Komaromy MS. Coping with HIV infection: why people delay care. Ann Intern Med. 1992;117:797.
27. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990;322:1037-1042.
28. Kahn JO, Lagakos SW, Richman DD, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med. 1992;327:581-587.
29. Cooke M. An in-depth look at P019: what the subjects are saying. Presented at the Conference on Adherence in AIDS Clinical Trials; April 25, 1991; San Francisco, Calif.
30. Kaslow RA, Blackwelder WC, Ostrow DG, et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals: a report from the Multicenter AIDS Cohort Study. JAMA. 1989;261:3424-3429.